Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

The treatment was effective and tolerable for advanced gastric cancer.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Anti-androgen therapy is crucial for treating cancer and hormone-related diseases, even with low testosterone levels.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The treatment combination is safe and effective for some patients with this type of breast cancer.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

5-ARI therapy may help prevent prostate cancer progression.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Home health occupational therapy should be included before chemotherapy to improve patient care.

A 70-year-old woman with a malignant adrenal tumor improved after surgery and radiotherapy.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.